Insider Trading February 4, 2026

Plexus Chairman Sells 5,000 Shares, Company Posts Solid Q1 Fiscal 2026 Results

Dean A. Foate reduced indirect holdings while restricted shares vested; Plexus reported EPS above estimates and revenue in line with projections

By Priya Menon PLXS
Plexus Chairman Sells 5,000 Shares, Company Posts Solid Q1 Fiscal 2026 Results
PLXS

Dean A. Foate, chairman of Plexus Corp, sold 5,000 shares on February 2, 2026, at $204.8935 for a total of $1024467, lowering his indirect holdings to 15,000 shares held in trust. The next day, 1,370 shares were recorded as acquired through the vesting and settlement of Restricted Stock Units. Separately, Plexus reported first-quarter fiscal 2026 results showing EPS of $1.78 versus a $1.75 analyst forecast and revenue of $1.07 billion in line with projections; the company's shares rose on the news and no analyst upgrades or downgrades were reported.

Key Points

  • Dean A. Foate sold 5,000 shares on February 2, 2026, at $204.8935, totaling $1024467, which reduced his indirect holdings to 15,000 shares held in trust.
  • On February 3, 2026, Foate acquired 1,370 Plexus common shares following the vesting and settlement of Restricted Stock Units.
  • Plexus reported Q1 fiscal 2026 EPS of $1.78 versus a $1.75 forecast and revenue of $1.07 billion in line with projections; shares rose after the announcement and no analyst upgrades or downgrades were reported.

Dean A. Foate, who serves as Chairman of the Board at Plexus Corp (NASDAQ:PLXS), executed an insider sale of common stock on February 2, 2026. The Form 4 filed with the Securities and Exchange Commission shows Foate sold 5,000 shares at a price of $204.8935 per share, for a reported total value of $1024467.

The filing indicates that the disposition reduced Foate's indirect holdings, leaving 15,000 shares held in trust. The transaction was followed the next day by an increase in Foate's direct holdings: on February 3, 2026, he acquired 1,370 shares of Plexus Corp common stock as a result of the vesting and settlement of Restricted Stock Units (RSUs).

Those insider moves came alongside the company’s latest quarterly results. For the first quarter of fiscal year 2026, Plexus reported earnings per share of $1.78, compared with a forecasted EPS of $1.75. Revenue for the quarter was reported at $1.07 billion, which the company said aligned with projections.

The combination of an EPS result above the analyst forecast and revenue consistent with expectations was noted in public reporting as indicative of a positive financial performance for the period. Following the release of the quarterly figures, Plexus shares experienced a notable increase. The reporting also noted that no analyst upgrades or downgrades were issued in connection with the earnings announcement.

Below is a concise recap of the factual items contained in public filings and the company’s earnings release:

  • Insider transaction: Dean A. Foate sold 5,000 shares on February 2, 2026, at $204.8935 for a total value of $1024467.
  • Post-sale holdings: Foate's indirect holdings were decreased to 15,000 shares held in trust, as shown on the Form 4 filing.
  • RSU vesting: On February 3, 2026, Foate acquired 1,370 Plexus common shares through vesting and settlement of Restricted Stock Units.
  • Quarterly results: Plexus reported EPS of $1.78 versus a $1.75 analyst forecast and revenue of $1.07 billion matching projections; shares rose after the announcement and no analyst rating changes were reported.

The information presented here is drawn from the company's SEC filing and its public quarterly results disclosure. The filings document both the insider transaction sequence and the core financial metrics reported for the quarter.

Risks

  • Future insider transactions could further change reported holdings; the filing records holdings as 15,000 shares held in trust after the February 2 sale, but does not disclose subsequent transactions beyond the February 3 RSU vesting.
  • Market reaction to quarterly results can evolve; while shares rose following the earnings release, no analyst upgrades or downgrades were reported at the time, leaving near-term analyst sentiment unchanged in public reporting.
  • The information presented is limited to the filed Form 4 and the company’s reported quarter; additional corporate developments or filings could alter the context but are not reflected here.

More from Insider Trading

Arcutis CFO Sells 1,320 Shares to Cover Tax Withholding; Company Reports Clinical, Commercial and Regulatory Milestones Feb 4, 2026 Arcutis Director Disposes $250K in Stock as Company Advances ZORYVE Program Feb 4, 2026 Alphatec EVP Sells 37,358 Shares in Pre-Set Plan as Company Reports Mixed Quarter Feb 4, 2026 Arista Director Sells 7,900 Shares for $1.12M as Stock Trades Below Sale Prices Feb 4, 2026 Eagle Point reduces small stake in ACRES Commercial Realty preferred shares for $118,216 Feb 4, 2026